Skip to content

Role Of Shubhdeep Liv-Gud Pill In Fatty Liver (Yakrutdalyodara)

A Clinical Study To Evaluate The Therapeutic Effect Of Shubhdeep Liv-Gud Pill In The Management Of Yakrutdalyodara W.S.R to Fatty Liver Disease.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023410
Enrollment
30
Registered
2020-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

Intervention1: Shubhdeep Liv-Gud Pill: 500 mg BID with lukewarm water Control Intervention1: NIL: NIL Control Intervention2: NIL: NIL

Sponsors

Shubhdeep Ayurveda Medical College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient presenting with clinical feature of yakrutdalyodara(Fatty liver). 2. Patient with or without the clinical feature of yakrutdalyodara, diagnosed to be having USG whole abdomen where include for the study. 3. Patient age between 20-60 years with either sex. 4. Patient of alcoholic addiction, obesity, type-2 diabetes mellitus.

Exclusion criteria

Exclusion criteria: 1. Patient aged less than 20 yr and more than 60 years. 2. Patient with hepatic encephalopathy, systemic multiorgan syndrom, malignency of liver and cirrhosis of liver and prehepatic and hepatic coma, bleeding disorder, etc. 3. Pregnent women. 4. Hepatitis B and C. 5. Patient on steroid treatment.

Design outcomes

Primary

MeasureTime frame
1) Improve power of digestion. 2) Relief in anorexia. 3) Relief in indigestion. 4) Relief in weakness. 5) Relief in fever. 6) Relief in constipation.Timepoint: 45th day.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Akhilesh shrivastava

Shubhdeep ayurved medical college and hospital, Indore

doctoraksingh@yahoo.com9300681233

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026